直 Japanese PDF Font
  • 구성원
  • 업무분야
  • 소식 및 자료
  • 사무소
  • Firm
  • 채용공고
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • 생명과학
    • Transportation and Logistics
  • 업무사례

의견서 및 자문

About

Evaluate your IP assets through opinions and counseling.

We render hundreds of opinions a year ranging from a single opinion on a specific patent to providing long-term, ongoing counseling on complex patent portfolios or litigation. We routinely address patent validity, enforceability, freedom to operate (FTO), misuse, design-around issues, licensing potential, IP contract construction and enforcement, and export controls. We regularly partner with our clients’ legal, business, and technical staffs to identify the potential for risk and reward, from idea to revenue-generating portfolios.

In addition to transactional counseling, we routinely advise clients on prelitigation strategies. Our extensive litigation experience gives us firsthand insight into the various types of arguments opponents may raise. Combining our litigation and IP transactional experience allows us to help guide our clients to favorable settlements of disputes before or during litigation.

Everyone in this practice

업무사례

Comprehensive patent transactions and strategic counseling for one of the largest pharmaceutical companies in the world

Finnegan is lead and preferred IP transactions counsel for one of the largest pharmaceutical companies in the world, handling more than 50 diligence projects each year, including all IP and related transactional aspects of the matters. The transactions span the full gamut of technologies from small molecule through biologics such as antibodies, oligonucleotides, and gene therapies. Finnegan also provides extensive assistance with post-deal integration procedures and subsequent global prosecution and portfolio strategy, ensuring a seamless transition of IP assets to the company and maximum value from acquired IP.

Global prosecution and portfolio management for major pharmaceutical company

Finnegan is lead and preferred IP strategy counsel for one of the largest pharmaceutical companies in the world, handling all aspects of prosecution and portfolio management for multiple top-tier products for the client.  The work spans the gamut from drafting and prosecution through larger strategic planning, patent term extension, and pre-litigation preparation on blockbuster small molecule and biologic products in the oncology, rheumatology, immunology, neuromuscular, and cell and gene therapy spaces.

IP services for Tetra Tech

Finnegan assists Tetra Tech, Inc., a leading provider of high-end consulting and engineering services, with comprehensive patent services including litigation, counseling, and opinions related to railroad technologies. Finnegan also provides trademark search, opinion, and prosecution services to Tetra Tech.

Patent services for leading electric flying taxi company Archer Aviation Inc.

Finnegan assists Archer Aviation, a leading urban air mobility company responsible for designing, developing, manufacturing, and operating electric vertical takeoff and landing aircrafts to carry passengers, with matters related to patent application drafting and global prosecution. We also provide patent counseling services.

Strategic patent counseling for collaboration technology company Huddly

Finnegan represents Huddly AS, a leading developer of advanced camera systems for team collaboration, in patent prosecution and counseling matters. The firm works closely with Huddly to shape a comprehensive patent strategy that protects its portfolio of videoconferencing technologies, which integrate design, hardware, software, and artificial intelligence (AI) to deliver intelligent, high-performance imaging solutions.

Utility and design patent applications for brain machine interface company

Finnegan represents BrainCo, a developer of brain-machine interface (BMI) wearables that combine electroencephalography (EEG) signal processing with artificial intelligence (AI) and machine learning (ML) to enable users to control electronic devices using brain signals. The firm works with BrainCo to develop and implement its intellectual property strategy, including drafting and prosecuting utility and design patent applications, in support of the company’s efforts to build a robust patent portfolio covering innovations and designs related to BMI technologies used in toys, smart home appliances, and robotic devices.

More

Insights

Federal Circuit IP Blog

Federal Circuit Reverses Eligibility of Software Claims Where Technical Improvements Were Not Reflected in Claims

April 15, 2026

Federal Circuit IP Blog

Federal Circuit Reverses Indefiniteness Ruling on Means-Plus-Function Claim

April 15, 2026

Webinar

When Machines Invent: Patenting Innovations in the Age of AI

July 15, 2025

Webinar

Books

Biosimilars Litigation and Client Counseling

June 17, 2024

Seminar

Mobility Innovation: Business & Patent Strategies for Driving Success

May 22, 2024

Tel Aviv

Webinar

IP Agreements: Structuring Indemnification and Limitation of Liability Provisions to Allocate Infringement Risk

January 11, 2024

Webinar

More

뉴스

Award/Ranking

10 Finnegan Attorneys Named to the 2023 IAM Strategy 300 List

October 5, 2023

Commentary

Eligibility Bill Gives Attys Relief, Even With 'Squishy' Terms

June 28, 2023

Announcement

Aaron Capron Named a 2023 Top Intellectual Property Lawyer

May 17, 2023

Commentary

How I Made Partner: Finnegan's Danielle Duszczyszyn Shares Six Keys to Business Development Success

December 16, 2020

Press Release

Esther H. Lim Nominated as Candidate for President-Elect of the D.C. Bar

March 6, 2017

Media Mention

Best Practice Series: Women’s Initiatives

March 17, 2015

More

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 개인정보처리방침
  • 면책공고
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP